Drugs / [68Ga]Ga-OncoCAIX
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06840548 | Apr → Nov 2025 | clear cell renal carcinoma | Philogen S.p.A. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [68Ga]Ga-OncoCAIX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06840548 ↗ |
| Modality | Diagnostic / imaging agent | “for imaging of ccRCC” NCT06840548 ↗ |
| Route | Intravenous | “Single intravenous bolus administration.” NCT06840548 ↗ |